ロード中...
ACTR-39. APPLICATION OF RTOG-RPA SCORES IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE (TTFIELDS/TMZ) VERSUS TEMOZOLOMIDE (TMZ) ALONE IN NEWLY DIAGNOSED GLIOBLASTOMA
BACKGROUND: A simplified model on prognostic factor recursive partitioning analysis (RPA) for survival of glioblastoma patients was previously published by the radiation therapy oncology group (RTOG) (Li et al. Int J Radiat Oncol Biol Phys. 2011). In this RPA model, patients are divided into three p...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692195/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.030 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|